RNA · Atrium Therapeutics, Inc.
$11.57
+0.03 (+0.26%)
At close · Jul 27
Market Cap
$196.54M
Shares
17.11M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
No structured figures reported for this view yet.
Key facts
CIK
2093101
CUSIP
04965N104
13F (30d)
21 filings
21 filers
Visit website
Investor relations